Björnsson E, Lefèvre J P, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3341312 A1, 2021-12-26.
发明人徐明华,王建平,刘建华. "Method for the Synthesis of 1,3-Dimethyl 2-(5-methyl-3-nitropyridin-2-yl)propanedioate" [P]. 中国发明专利, 专利号 CN 113100201 B, 授权公告日 2015-08-09.
发明人冯建国,唐晓军,徐明华. "A Process for Preparing High-Purity 1,3-Dimethyl 2-(5-methyl-3-nitropyridin-2-yl)propanedioate" [P]. 中国发明专利, 专利号 CN 109730452 B, 授权公告日 2021-03-15.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2022, 139, (4), 4835-4852.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2018, 1246, (9), 5708-5716.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 1,3-Dimethyl 2-(5-methyl-3-nitropyridin-2-yl)propanedioate Using HRMS and NMR". Biomed. Chromatogr., 2013, 2368, (7), 731-747.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2015, 2107, (1), 1397-1422.